These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3688306)

  • 1. Antimalarial activity of a riboflavin analog against Plasmodium vinckei in vivo and Plasmodium falciparum in vitro.
    Cowden WB; Butcher GA; Hunt NH; Clark IA; Yoneda F
    Am J Trop Med Hyg; 1987 Nov; 37(3):495-500. PubMed ID: 3688306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial action of flavin analogues seems not be due to inhibition of glutathione reductase of host erythrocytes.
    Halladay PK; Hunt NH; Butcher GA; Cowden WB
    Biochem Pharmacol; 1990 Mar; 39(6):1063-5. PubMed ID: 2182031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
    Rosenthal PJ; Lee GK; Smith RE
    J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.
    Nicolas O; Margout D; Taudon N; Wein S; Calas M; Vial HJ; Bressolle FM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3631-9. PubMed ID: 16127032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of atalaphillinine and related acridone alkaloids against rodent malaria.
    Fujioka H; Nishiyama Y; Furukawa H; Kumada N
    Antimicrob Agents Chemother; 1989 Jan; 33(1):6-9. PubMed ID: 2653215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roseoflavin, a Natural Riboflavin Analogue, Possesses
    Hemasa AL; Mack M; Saliba KJ
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0054022. PubMed ID: 36094195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antiplasmodial activity of Momordica balsamina alone or in a traditional mixture.
    Benoit-Vical F; Grellier P; Abdoulaye A; Moussa I; Ousmane A; Berry A; Ikhiri K; Poupat C
    Chemotherapy; 2006; 52(6):288-92. PubMed ID: 17008780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
    Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
    Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bis-alkylamidoxime O-alkylsulfonates as orally available antimalarials.
    Degardin M; Wein S; Gouni S; Tran Van Ba C; Duckert JF; Durand T; Escale R; Vial H; Vo-Hoang Y
    ChemMedChem; 2012 Jun; 7(6):991-1001. PubMed ID: 22544438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavin analogs with antimalarial activity as glutathione reductase inhibitors.
    Becker K; Christopherson RI; Cowden WB; Hunt NH; Schirmer RH
    Biochem Pharmacol; 1990 Jan; 39(1):59-65. PubMed ID: 2404494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial activity of synthetic riboflavin antagonists.
    Cowden WB; Clark IA
    Trans R Soc Trop Med Hyg; 1987; 81(4):533. PubMed ID: 3484362
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex Vivo Maturation Assay for Testing Antimalarial Sensitivity of Rodent Malaria Parasites.
    Chang ZW; Malleret B; Russell B; Rénia L; Claser C
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6859-6866. PubMed ID: 27600050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium vinckei petteri: identification of the stages sensitive to arteether.
    Caillard V; Beauté-Lafitte A; Chabaud AG; Landau I
    Exp Parasitol; 1992 Dec; 75(4):449-56. PubMed ID: 1493877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.
    Caldarelli SA; Boisbrun M; Alarcon K; Hamzé A; Ouattara M; Salom-Roig X; Maynadier M; Wein S; Peyrottes S; Pellet A; Calas M; Vial H
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3953-6. PubMed ID: 20605450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Coptis teeta Wall. for antimalarial effect: a preliminary report.
    Sharma SK; Satyanarayana S; Yadav RN; Dutta LP
    Indian J Malariol; 1993 Sep; 30(3):179-81. PubMed ID: 8131885
    [No Abstract]   [Full Text] [Related]  

  • 18. The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo.
    Chen M; Brøgger Christensen S; Zhai L; Rasmussen MH; Theander TG; Frøkjaer S; Steffansen B; Davidsen J; Kharazmi A
    J Infect Dis; 1997 Nov; 176(5):1327-33. PubMed ID: 9359735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylic ionophores in malaria chemotherapy: the effects of monensin and nigericin on Plasmodium falciparum in vitro and Plasmodium vinckei petteri in vivo.
    Adovelande J; Schrével J
    Life Sci; 1996; 59(20):PL309-15. PubMed ID: 8890952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the first oral bioprecursors of bis-alkylguanidine antimalarial drugs.
    Degardin M; Wein S; Duckert JF; Maynadier M; Guy A; Durand T; Escale R; Vial H; Vo-Hoang Y
    ChemMedChem; 2014 Feb; 9(2):300-4. PubMed ID: 24403182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.